Register to receive a free US Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials report synopsis and brochure

The acclaimed researchers and manufacturers of NanoGen and DentoGen—the specialists at Orthogen, LLC—strive to create superior dental bone grafting materials. With roots at New York University and operating as a division of BioLok International, Orthogen, LLC went on to develop its own patented LaserLok line of dental implants. By 2007, the company had true independence, continuing to research and market the most innovative dental bone grafting materials in the dental industry.

Orthogen LLC’s NanoGen is manufactured by the company utilizing a proprietary technology. A calcium sulfate powder is structurally converted down to nanocrystalline grains of no more than 200 to 900 nanometers. The powder then forms dense particles that range between 400 to 1000 microns. Because of the unique chemistry of these particles, NanoGen gives results that cannot be paralleled by other grafting materials.

Approved as a stand-alone bone grafting material and a complement to other dental grafting materials, DentoGen boasts all the strengths of its medical grade calcium sulfate. Being completely synthetic, biodegradable, osteoconductive, and a non-toxic material, DentoGen has the safety and surgical potential to successfully stimulate bone ingrowth into defects. The product is used by dental professionals during root perforations, as well as apicoectomies and other dental and orthodontic procedures.

Orthogen, LLC prides itself on the quality of its dental bone graft products—ensuring successes in oral surgeries.

About Orthogen, LLC

Originally a division of BioLok International, which is now merged with BioHorizons, Orthogen, LLC was established in 2007 to develop and market next generation bone-grafting products for orthopedic and dental applications.

Source: http://www.sbwire.com/press-releases/orthogen-llc-strives-to-create-superior-dental-bone-graft-materials-951335.htm

For Further Information

More on the dental bone graft substitute market in the U.S. can be found in a series of reports published by iData Research entitled the U.S. Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials. The suite covers reports on the following markets: dental bone graft substitutes, dental growth factors and dental barrier membranes.

The iData report series on dental bone graft substitutes covers the U.S., Argentina, Brazil, Mexico, China, Australia, Japan, South Korea and 15 countries in Europe including Germany, France, the United Kingdom (U.K.), Italy, Spain, Benelux (Belgium, Netherlands and Luxemburg), Scandinavia (Finland, Denmark, Sweden and Norway), Portugal, Austria and Switzerland. Reports provide a comprehensive analysis including units sold, market value, forecasts, as well as detailed competitive market shares and analysis of major players’ success strategies in each market and segment. To find out more about dental bone graft substitutes market data, register online or email us at [email protected] for a U.S. Market Report Suite for Dental Bone Graft Substitutes and Other Biomaterials brochure and synopsis.